Spero Therapeutics News

Spero Therapeutics | ARS: Annual Report to Security Holders

Apr 17 04:21

Spero Therapeutics | DEFA14A: Others

Apr 17 04:21

Spero Therapeutics | DEF 14A: Definitive information statements

Apr 17 04:17

Spero Therapeutics | 8-K: Current report

Mar 30 04:17

Spero Therapeutics | EFFECT: Others

Mar 25 18:03

Spero Therapeutics | CORRESP: CORRESP

Mar 21 01:56

Spero Therapeutics | UPLOAD: Others

Mar 21 01:56

Spero Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Mar 16 04:42

Spero Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 16 04:24

Spero Therapeutics | 10-K: Annual report

Mar 14 04:15

Spero Therapeutics | 8-K: Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update

Mar 14 04:11

Spero Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Anson Funds Management LP(8.1%),Anson Management GP LLC(8.1%), etc.

Feb 15 06:38

Spero Therapeutics | 8-K: Current report

Feb 10 05:12

Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Keutzer Timothy

Feb 6 09:59

Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Mahadevia Ankit

Feb 6 09:54

Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer JOSEPH TAMARA L

Feb 6 09:54

Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer HAMED KAMAL

Feb 6 09:49

Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rajavelu Esther

Feb 6 09:49

Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Shukla Sath

Feb 6 09:44

Spero Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 6 05:54